BCL2 in breast cancer: A favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received (British Journal of Cancer (2010) 103 (668675) Doi:10.1038/sj.bjc.6605736)

S. J. Dawson; N. Makretsov; F. M. Blows; K. E. Driver; E. Provenzano; J. Le Quesne; L. Baglietto; G. Severi; G. G. Giles; C. A. McLean; G. Callagy; A. R. Green; I. Ellis; K. Gelmon; G. Turashvili; S. Leung; S. Aparicio; D. Huntsman; C. Caldas; P. Pharoah

doi:10.1038/sj.bjc.6605921

BCL2 in breast cancer: A favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received (British Journal of Cancer (2010) 103 (668675) Doi:10.1038/sj.bjc.6605736)

S. J. Dawson^*
, N. Makretsov
, F. M. Blows
, K. E. Driver
, E. Provenzano
, J. Le Quesne
, L. Baglietto
, G. Severi
, G. G. Giles
, C. A. McLean
, G. Callagy
, A. R. Green
, I. Ellis
, K. Gelmon
, G. Turashvili
, S. Leung
, S. Aparicio
, D. Huntsman
, C. Caldas
, P. Pharoah

^*Corresponding author for this work

Department of Immunology and Cancer Research

Research output: Contribution to journal › Comment/debate

2 Scopus citations

Original language	English
Pages (from-to)	1137
Number of pages	1
Journal	British Journal of Cancer
Volume	103
Issue number	7
DOIs	https://doi.org/10.1038/sj.bjc.6605921
State	Published - 28 Sep 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1038/sj.bjc.6605921

Cite this

Dawson, S. J., Makretsov, N., Blows, F. M., Driver, K. E., Provenzano, E., Le Quesne, J., Baglietto, L., Severi, G., Giles, G. G., McLean, C. A., Callagy, G., Green, A. R., Ellis, I., Gelmon, K., Turashvili, G., Leung, S., Aparicio, S., Huntsman, D., Caldas, C., & Pharoah, P. (2010). BCL2 in breast cancer: A favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received (British Journal of Cancer (2010) 103 (668675) Doi:10.1038/sj.bjc.6605736). British Journal of Cancer, 103(7), 1137. https://doi.org/10.1038/sj.bjc.6605921

@article{4dbfe379fc174dd6bbf605c4e39aad8e,

title = "BCL2 in breast cancer: A favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received (British Journal of Cancer (2010) 103 (668675) Doi:10.1038/sj.bjc.6605736)",

author = "Dawson, \{S. J.\} and N. Makretsov and Blows, \{F. M.\} and Driver, \{K. E.\} and E. Provenzano and \{Le Quesne\}, J. and L. Baglietto and G. Severi and Giles, \{G. G.\} and McLean, \{C. A.\} and G. Callagy and Green, \{A. R.\} and I. Ellis and K. Gelmon and G. Turashvili and S. Leung and S. Aparicio and D. Huntsman and C. Caldas and P. Pharoah",

year = "2010",

month = sep,

day = "28",

doi = "10.1038/sj.bjc.6605921",

language = "אנגלית",

volume = "103",

pages = "1137",

journal = "British Journal of Cancer",

issn = "0007-0920",

publisher = "Springer Nature",

number = "7",

}

Dawson, SJ, Makretsov, N, Blows, FM, Driver, KE, Provenzano, E, Le Quesne, J, Baglietto, L, Severi, G, Giles, GG, McLean, CA, Callagy, G, Green, AR, Ellis, I, Gelmon, K, Turashvili, G, Leung, S, Aparicio, S, Huntsman, D, Caldas, C & Pharoah, P 2010, 'BCL2 in breast cancer: A favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received (British Journal of Cancer (2010) 103 (668675) Doi:10.1038/sj.bjc.6605736)', British Journal of Cancer, vol. 103, no. 7, pp. 1137. https://doi.org/10.1038/sj.bjc.6605921

BCL2 in breast cancer: A favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received (British Journal of Cancer (2010) 103 (668675) Doi:10.1038/sj.bjc.6605736). / Dawson, S. J.; Makretsov, N.; Blows, F. M. et al.
In: British Journal of Cancer, Vol. 103, No. 7, 28.09.2010, p. 1137.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - BCL2 in breast cancer

T2 - A favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received (British Journal of Cancer (2010) 103 (668675) Doi:10.1038/sj.bjc.6605736)

AU - Dawson, S. J.

AU - Makretsov, N.

AU - Blows, F. M.

AU - Driver, K. E.

AU - Provenzano, E.

AU - Le Quesne, J.

AU - Baglietto, L.

AU - Severi, G.

AU - Giles, G. G.

AU - McLean, C. A.

AU - Callagy, G.

AU - Green, A. R.

AU - Ellis, I.

AU - Gelmon, K.

AU - Turashvili, G.

AU - Leung, S.

AU - Aparicio, S.

AU - Huntsman, D.

AU - Caldas, C.

AU - Pharoah, P.

PY - 2010/9/28

Y1 - 2010/9/28

UR - https://www.scopus.com/pages/publications/77957221496

U2 - 10.1038/sj.bjc.6605921

DO - 10.1038/sj.bjc.6605921

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

AN - SCOPUS:77957221496

SN - 0007-0920

VL - 103

SP - 1137

JO - British Journal of Cancer

JF - British Journal of Cancer

IS - 7

ER -

BCL2 in breast cancer: A favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received (British Journal of Cancer (2010) 103 (668675) Doi:10.1038/sj.bjc.6605736)

UN SDGs

Access to Document

Other files and links

Cite this